1.Xinyi Wu, Ping Sun, Xiuhui Chen, Lei Hua, Haowei Cai, Zhuorong Liu, Cheng Zhang, Shuli Liang,
Yanhong Chen, Dan Wu, Yitao Ou, Wenhui Hu*, and Zhongjin Yang*. Discovery of a novel oral proteasome
inhibitor to block NLRP3 inflammasome activation with anti-inflammation activity. Journal of Medicinal
Chemistry. 2022 Sep 22, 65(18):11985-12001.
2.Yanhong Chen#, Xiuhui Chen#, Shuli Liang, Yitao Ou, Geng Lin, Lei Hua, Xinyi Wu, Yinghua Zhou,
Zhuorong Liu, Haowei Cai, Zhongjin Yang, Wenhui Hu*, and Ping Sun*. Chlorquinaldol inhibits the
activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing
protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
Chemico-Biological Interactions, 2022, 365:110122.
3.Shuli Liang, Zhongjin Yang, Lei Hua, Yanhong Chen, Yinghua Zhou, Yitao Ou, Xiuhui Chen, Hu Yue,
Xiangyu Yang, Xinyi Wu, Wenhui Hu*, and Ping Sun*. Ciclopirox inhibits NLRP3 inflammasome activation
via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice. European
Journal of Pharmacology, 2022, 930:175156.
4.Zhihua Huang, Zhengwei Luo, Andrea Ovcjak, Jiangfan Wan, Naihong Chen, Wenhui Hu, HongShuo
Sun, ZhongPing Feng. AD-16 Protects Against Hypoxic-Ischemic Brain Injury by Inhibiting
Neuroinflammation. Neuroscience Bulletin. 2022, 38: 857–870.
5.Ying Hao, Yitao Ou, Cheng Zhang, Hao Chen, Hu Yue, Zhongjin Yang, Xiaofen Zhong, Wenhui Hu*,
and Ping Sun*. Seratrodast, a thromboxane A2 receptor antagonist, inhibits neuronal ferroptosis by
promoting GPX4 expression and suppressing JNK phosphorylation. Brain Research. 2022, 148073.